OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease
Lorenzo Barba, Samir Abu‐Rumeileh, Steffen Halbgebauer, et al.
Neurology (2023) Vol. 101, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Neurofilaments as biomarkers in neurological disorders — towards clinical application
Michael Khalil, Charlotte E. Teunissen, Sylvain Lehmann, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 5, pp. 269-287
Closed Access | Times Cited: 102

Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 8

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1

Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies
Agathe Vrillon, Olivier Bousiges, Karl Götze, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5

Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer’s pathophysiological biomarkers
Alba Cervantes‐González, Julie Goossens, E. Vera Campuzano, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access

Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis
Samir Abu‐Rumeileh, Leila Motlagh Scholle, Alexander Mensch, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke
Lorenzo Barba, Christoph Vollmuth, Samir Abu‐Rumeileh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12

Single- versus two-test criteria for cognitive impairment: associations with CSF and imaging markers in former American football players
Monica T. Ly, Caroline Altaras, Yorghos Tripodis, et al.
The Clinical Neuropsychologist (2025), pp. 1-25
Closed Access

The Role of α-Synuclein in Etiology of Neurodegenerative Diseases
Daria Krawczuk, Magdalena Groblewska, Jan Mroczko, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9197-9197
Open Access | Times Cited: 3

CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases
Lorenzo Barba, G. Bellomo, Patrick Oeckl, et al.
Journal of the Neurological Sciences (2024) Vol. 462, pp. 123059-123059
Closed Access | Times Cited: 2

Contribution of alpha‐synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI
Samir Abu‐Rumeileh, G Arajyan, Eric M. Reiman, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 2

Mild cognitive impairment in dementia with Lewy bodies: an update and outlook
K. A. Jellinger
Journal of Neural Transmission (2023) Vol. 130, Iss. 12, pp. 1491-1508
Closed Access | Times Cited: 4

Plasma biomarkers of amyloid, tau, axonal and neuroinflammation pathologies in dementia with Lewy bodies
Agathe Vrillon, Olivier Bousiges, Karl Götze, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1

Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?
Giuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment
Florian Krismer, Alessandra Fanciulli, Wassilios G. Meissner, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 12, pp. 1252-1266
Closed Access | Times Cited: 1

The Underestimated Relevance of Alzheimer’s Disease Copathology in Amyotrophic Lateral Sclerosis
Lorenzo Barba, Markus Otto, Samir Abu‐Rumeileh
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 4, pp. 1401-1404
Closed Access | Times Cited: 3

Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: Case Report and Review of the Literature
Federico Verde, Edoardo Nicolò Aiello, Laura Adobbati, et al.
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 4, pp. 1383-1399
Closed Access | Times Cited: 2

Research advancement in fluid biomarkers for Parkinson’s disease
Lorenzo Gaetani, Federico Paolini Paoletti, Alessandro Mechelli, et al.
Expert Review of Molecular Diagnostics (2024)
Closed Access

CSF synaptic biomarkers and cognitive impairment in multiple sclerosis
Lorenzo Barba, Lorenzo Gaetani, Silvia Sperandei, et al.
Journal of Neurology (2024) Vol. 272, Iss. 1
Open Access

Tackling the usefulness of neurofilament light chain in multiple system atrophy: diagnostic and prognostic perspectives
Daniel G. Di Luca, Patricio Millar Vernetti
Clinical Autonomic Research (2023) Vol. 33, Iss. 6, pp. 617-618
Open Access

Page 1

Scroll to top